Cytotoxicity testing of carrier-based microcomposites for DPI application.

Area of Science:

• Pharmacology
• Drug Delivery
• Cell Biology

Background:

• Inhalation offers a promising route for systemic and local drug delivery.
• High local drug concentrations via inhalation can reduce side effects and improve therapeutic outcomes.
• Previous research established carrier-based microcomposites for inhalation.

Purpose of the Study:

• To evaluate the cytotoxicity of meloxicam-loaded microcomposites on Calu-3 lung cells.
• To determine the safety and potential efficacy of these microcomposites for pulmonary drug delivery.
• To establish a link between drug dissolution and cytotoxicity for optimizing dry powder inhaler formulations.

Main Methods:

• Cytotoxicity assays were performed on Calu-3 cell monolayers.
• Meloxicam-containing microcomposites were tested.
• Drug dissolution profiles were analyzed in conjunction with cytotoxicity data.

Main Results:

• Cytotoxicity data provides insights into the safety of meloxicam microcomposites.
• The study establishes a relationship between meloxicam dissolution and cellular response.
• Information was gathered to guide the formulation of safe and effective dry powder inhalers.

Conclusions:

• Cytotoxicity assessment is crucial for developing safe pulmonary drug delivery systems.
• Relating cytotoxicity to drug dissolution enables the determination of appropriate drug loading for inhalation.
• This research supports the advancement of meloxicam-based dry powder inhalation therapies.